Abstract
Material and methods. The short- and long-term results of phacoemulsification with implantation of 700 Clareon intraocular lenses (IOL) preloaded into disposable pneumatic AutonoMe delivery systems were studied. The optical power of the IOL was calculated using the Verion system using modern formulas for emmetropia. Functional and refractive results, surgical and postoperative complications were assessed. Results. Of the 700 Clareon IOL implantations performed, 693 (99.0%) were without complications; complications occurred in 7 (1.0%) eyes. By 12 months of observation, BCDVA and UCDVA increased from 0.15±0.03 to 0.65±0.09 and from 0.31±0.04 to 0.76±0.12 (p<0.05), respectively. Refraction of the target was achieved in 90% of patients. The loss of endothelial cells from the baseline level was 4.8%. In all patients, the optical part of the IOL remained stably transparent, no glistening phenomena were observed in any case; the haptic component of the IOL provided a stable correct central position of the IOL in the capsule bag. Secondary cataract developed in 22/605 (3.6%) eyes, which required dissection in 19/605 (3.1%) eyes. Conclusion. The new monofocal intraocular lens Clareon is high-tech and can be widely used in clinical practice. The new automated pneumatic delivery system AutonoMe is efficient and safe. Key words: phacoemulsification, Clareon, automatic IOL delivery system, glistening, secondary cataract
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
